Company intelligence / Profile preview

Breezing Up

Ownership: Private
Development stage: Other

Overview

The Breezing device has demonstrated in published clinical studies that patients using it experienced twice as much weight loss and 70% better adherence to healthy behaviors compared to controls. The technology is FDA-cleared for cleaning/disinfection protocols and widely used in both research and clinical settings including Mayo Clinic, Harvard University, Banner Health, and private clinics worldwide.

Therapeutic areas: Metabolic DisordersEndocrinology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Mayo ClinicHarvard University Sports Program

Beyond the preview

Go deeper on Breezing Up.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Breezing Up.

Explore the full profile